Top 5 Stocks Recommend by JM Financial
JM Financial advises to buy these 5 stocks: JM Financial is a leading stock market research company.
After the release of the financial results of the second quarter of the companies listed in the stock market of this company, it has been advised to invest in 5 companies.
JM Financial believes that the work of these 5 companies is very good and it will continue to grow rapidly. This is the reason that good profits can be earned on investing in these companies.
Let us know which are these 5 companies. The price target being mentioned here means that the shares of the companies can come at this rate during 1 year.
ONGC
ONGC is advised to buy post quarterly results. At present, the share of ONGC is trading at around Rs.135 level. But JM Financial has a buy recommendation on the stock. JM Financial has given a target price of Rs 205 for the stock.
ABB India
JM Financial has a buy rating on ABB India. After releasing good quarterly financials, JM Financial has said that ABB stock can be bought keeping a target of Rs 3,350. At present the share rate of ABB India is Rs 3,070.00.
Biocon
Biocon has released excellent quarterly results. Due to this, JM Financial has advised to buy on this stock. JM Financial has said that Biocon’s share can go up to Rs 395. At the same time, this share is currently trading around Rs.282.
Mindspace REIT
Mindspace Business Park REIT has released good financial results in the second quarter of the current financial year.
Due to this, JM Financial has issued a buy advice on this stock. JM Financial has a buy call with a target price of Rs 375. At the same time, the rate of Mindspace REIT is running at Rs.344.
Apollo Tires
JM Financial has maintained a buy rating on Apollo Tires citing strong financial results.
JM Financial has said that looking at the financial results, it can be said that this stock can get a price target of Rs 350. At the same time, the share of Apollo Tires is trading at the level of Rs 284.10.
Disclaimer: This price target has been issued by JM Financial. It is a research company. But even after this it is advised to consult your financial advisor before investing.
